Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIDER-MAN Trial: Potassium-sparing diuretics with mannitol in neurocritical care
2011-000197-53Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cerebral edema and Cerebellar edema comparing Potassium canrenoate + mannitol with Placebo + mannitol (2 arms). Primary endpoint: 24-hour urinary potassium excretion from day 1 to day 8. Started Mar 2012; status: active.
02
Drugs
potassium canrenoate
03
Conditions
cerebral edemaCerebellar edema
Beyond the preview
Go deeper on 2011-000197-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000197-53.